We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Kit Helps Assess Total Patient Antioxidant Status

By LabMedica International staff writers
Posted on 24 Sep 2009
A total antioxidant status (TAS) kit complements a wide range of antioxidant products enabling a complete profile of a patient's antioxidant status.

Antioxidant levels can aid identification of disease risk in conditions such as cardiovascular disease, diabetes, cancer, and rheumatoid arthritis. More...
Information from antioxidant status can be used to optimize treatment regimes. The TAS kit can also be employed for food and beverage analysis and to assess the antioxidant potential of drugs.

Antioxidants help defend the body against free radicals, which are highly reactive molecules that have been implicated in the development of over 100 diseases affecting all major organs in the body. Many diseases have been associated with low antioxidant levels.

The Randox (Crumlin, UK) TAS kit is a cost-effective, easy to use method that provides rapid analysis and can be automated on most clinical chemistry analyzers. Calibrators and controls are available to enhance testing facilities. Antioxidant products available from Randox include albumin, bilirubin, ferritin, glutathione reductase, glutathione peroxide, superoxide dismutase, total iron binding content, transferrin, and uric acid.

Randox develops, manufactures, and markets clinical diagnostic products worldwide. It's core products are biochip array technology; clinical chemistry analyzers and reagents; quality controls; and recombinant proteins and antibodies.

Related Links:

Randox




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HPV Molecular Test
BD Onclarity HPV Assay
New
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.